Svetlana Lucas
Director · Jasper Therapeutics, Inc.
IndividualBuying only
- 2025
- Aug 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Svetlana Lucas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Behzad Aghazadeh - $36.26M in SCTX purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $15.00M in SCTX purchases and sales in the last 12 months
- Carl L. Gordon - $15.00M in SCTX purchases and sales in the last 12 months
- AH Bio Fund II, L.P. - $5.00M in SCTX purchases and sales in the last 12 months
- David Parrot - $40K in SCTX purchases and sales in the last 12 months
- Patrick J. Crutcher - JSPR
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Svetlana Lucas?
Svetlana Lucas is a corporate insider, tracked as Director of Jasper Therapeutics, Inc. (JSPR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Svetlana Lucas submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Svetlana Lucas been buying or selling stock?
Recorded transactions: 3 open-market purchases ($94K) and 0 open-market sales across all tracked filings.
